RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > China: New Draft Rules On Excipients

China: New Draft Rules On Excipients

Posted 05 June 2012 | By Louise Zornoza

China's State Food and Drug Administration (SFDA) issued draft rules on 4 June that would require pharmaceutical manufacturers to establish a system of ensuring the quality of the excipients they use in their drug production. 

The draft establishes drug manufacturers as having the primary responsibility to assure the quality of excipients obtained from suppliers

The goal of the draft rules is to "realize the full supervision of the pharmaceutical production and supply chain," SFDA said in a statement.

Read more:

SFDA - Draft Rules on Excipients
More Breaking News from RegLink

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.